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ABSTRACT
Background and the purpose of the study: Artemisinin is one of the most effective medicine 
against malaria, which is produced naturally by Artemisia annua in low yield. It is produced in a 
metabolic pathway, in which several genes and gene products are involved. One of the key genes 
in this pathway is am1, which encodes amorpha-4, 11-diene synthase (ADS), a key enzyme in 
artemisinin biosynthesis pathway. The aim of this study was to determine the presence of this 
gene in ten Artemisia species in order to increase the yield of production of Artemisinin. 
Methods: The experiments were carried out using PCR. Specific primers were designed based on 
the published am1 gene sequence obtained from A. annua (NCBI, accession number AF327527). 
Results: The amplification of this gene by the specific primers was considered as a positive sign 
for the potentiality of artemisinin production. Since the entire am1 gene was not amplified in any 
of the 10 species used, four parts of the gene, essential in ADS enzyme function, corresponding 
to a) pair site of Arg10-Pro12 in the first 100 amino acids, b) aspartate rich motif (DDXXD), c) 
active site final lid and d) active site including farnesyl diphosphate (FDP) ionization sites and 
catalytic site in the ADS enzyme, were investigated. 
Major conclusion: The sequence corresponding to ADS active site was amplified only in A. 
annua, A. aucheri and A. chamaemelifolia. The negative results obtained with other species 
could be due to some sequence alteration, such as point mutations or INDELs. We propose A. 
aucheri and A. chamaemelifolia as two potential candidate species for further characterization, 
breeding and transferring am1 gene for artemisinin overproduction.
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INTRODUCTION
Human malaria is an important cause of mortality 
in tropical regions and have been reported to affect 
300–500 million people worldwide annually. 
Infection with Plasmodium falciparum accounts for 
200–250 million cases, of which around 2 million 
are fatal (1). Artemisia annua L. is the main source 
for Artemisinin extraction. At the present, the 
World Health Organization (WHO) has recognised 
this sesquiterpene 3-oxane and its derivates 
(arteether, artesunate, artemether) obtained from 
A. annua as one of the most effective medicines 
for curing malaria. Artemisinin is a novel drug in 
the treatment of malaria, especially in those areas 
where resistance to quinine derivatives is common 
(2, 3). Artemisinin is the last effective drug against 
deadly resistant strains of P. falciparum (4). The first 
step in artemisinin biosynthesis is the cyclisation 
of farnesyl diphosphate (FDP) by amorpha-4,11-
diene synthase (ADS) (5). At the present time the 
extraction of artemisinin from A. annua plants 
seems to be the only source of this medicine (6). 
The chemical synthesis of artemisinin is not cost 
effective and the toxicity of by-products is also 
another problem (7, 8). Employment of cell and 
callus culture has not been promising, since a certain 
level of differentiation is required for artemisinin 
production (9). The yield of Artemisinin production 
by the plant A. annua is relatively low ranging from 
0.01% to 0.5% on the basis of dry weight (6). An 
alternative for the production of artemisinin in 
higher amounts have been proposed as the selection 
and breeding of high artemisinin yielding cultivars 
(10). In this investigation presence of ADS encoding 
gene (am1) in ten different species of Artemisia 
growing in Iran was examined to discover potential 
candidate species for further characterization, and 
possibly am1 gene transfer to increase artemisinin.
MATERIALS AND METHODS
Plant materials 
The seeds of all Artemisia species except A. 
draconculus, were gifted by Dr. Razban (Research 
332Institute for Forests and Rangelands; RIFR). The 
seeds had been collected during summer 2008, from 
different parts of Iran (Table 1). Seeds were sterilized 
in 5% (v/v) bleach for 10 min, followed by 3 times 
washings in double sterilised distilled water. For 
breaking seed dormancy, they were stored at 4°C for 
72 hrs, then germinated in a 0.5 X MS medium (11), 
supplemented with 3% (w/v) sucrose of pH 5.9 and 
0.8% (w/v) plant agar. After germination, seeds were 
subcultured in 1 X MS medium containing 1.5% 
(w/v) sucrose, 1.5% (w/v) glucose and incubated 
at 25°C ± 1 and 16/8 h light/dark photoperiod with     
55.5 µmol m-2 s-1 illumination, according to the 
report of Weathers et al. (12).
DNA extraction
Genomic DNA extraction from fresh medicinal 
plants such as Artemisia is a difficult task due to the 
presence of high amounts of secondary metabolites. 
A method (13) was chosen and carried out with some 
modifications to reduce the secondary metabolites 
and polysaccharides contents.
About 0.1 g of the leaf tissue was grounded to 
a  fine  powder  by  liquid  nitrogen  in  a  pestle  and 
mortar. The powder was transferred into a microtube 
containing 350 µl of the extraction buffer [2% (w/v) 
CTAB, 100 mM Tris-HCl, 20 mM EDTA, 1.4 M 
NaCl, 2% (w/v) PVP, 2% (v/v) 2-mercaptoethanol] 
and 350 µl 8 M lithium chloride, both pre-warmed 
at 65 °C and incubated for 45 min, with occasional 
inversions at 10 min intervals. An equal volume 
of chloroform: isoamyl alcohol 24 : 1 was 
added and tubes were shaken at 50 rpm for 20 
min. Microtubes were centrifuged at 13000 rpm 
(Labnet, UK) for 5 min at room temperature and 
supernatant was transferred into a new tube. To 
each tube were added, 0.15 M sodium acetate 
(5 M) and 0.6 vol ice cold isopropanol and then 
inverted gently, untill DNA bundles appeared. 
Tubes were transferred to a -20 °C freezer and 
left for one hour and then centrifuged at 13000 
rpm (Labnet, UK) for 10 min and supernatant was 
poured out. An aliquot of 300 µl of 70% ethanol 
(v/v) was added to the pellets and centrifuged at 
13000 rpm (Labnet, UK) for 5 min. Supernatant 
was poured out, pellet were air dried and 10-50 
µl sterilized double distilled water was  added to 
each tube. DNA samples were stored at -70 °C for 
future uses.
Primers
Primers were designed purely based on the DNA 
sequences (NCBI accession number AF327527) 
on the am1 gene (with the length of 4392 bp) 
corresponding to amino acid residues, important 
for ADS function (14). Also conserved sequences 
in mono and sesquiterpene synthases (3, 4), and 
sesquiterpene cyclases in dicotiledons (2) were 
considered in primer design (Table 2). Position of 
the primers on the am1 gene is shown in figure 1. 
Species Collection place Specimen* No. Species Collection place Specimen No.
A. annua Gorgan 1595 A. fragrance Jolfa 19969
A. aucheri Yazd 4500 A. cina Karaj 923
A. siberi Isfahan  10132 A. austerica Sarab 2953
A. vulgaris Urmiah 3709 A. draconculus** --------- ----------
A. scoparia Zanjan 1298 A. chamaemelifolia Tabriz 15385
Table 1. Artemisia species used in this study.
* The specimen numbers are available in the Research Institute of Forests and Rangelands of Iran.
** This species was purchased from local shops.
Primer Sequence 5’ to 3’ Amplification region Tm ºC
F1 CCTCCTTCAACCGTTACCCCG  Arg10-Pro12 site 75
R1 GCGAGAAGGATACCAAGGCAG  Conserved sequence 73.2
F2 CTTCTCGCCAGTGGTAGGGTCA Conserved sequence 75
R2 GAAGATACTCCCATCGACCCCT Conserved sequence 73.2
F3 GCTAACGAACTTGCGAGGTAGA FDP ionization site 71.3
R3 CGTTTCCTCCCTTCTTGTCTAG Conserved sequence 71.3
F4 CGGACTTGGATCAGGGGTTTTC Active site 73.2
R4 ATGGTTAGGAAGCACGTATCGG Catalytic site 71.3
F5 GCTTAAAGGGAAACGGCAAC Start point  68.9
R5 CATGATGTGTATAGCGTGC Catalytic site  65.4
Table 2. Primers designed according to am1 gene sequence.
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Following 4 parts were investigated in am1 gene:
a)  Pair  site  of  Arg10-Pro12  in  the  first  100 
amino acids using primers F1-R1. The expected 
amplification product was a 412 bp fragment.
b)  Aspartate rich motif (DDXXD), using primers 
F2-R2. This motif is the binding site of substrate. 
Primers F2 and R2 lie on exons 2 and 3, respectively. 
The expected amplification fragment was 1870 bp 
long and includes the intronic part of the gene.
c)  Active site, using primers F3-R3, F3-R4, F4-R4 
and F3-R5. This site is formed by three amino acids; 
Asp 444, Tyr 520 and Asp 524 and includes FDP 
ionization and catalytic sites. Primers F3-R3, F3-
R4 and F4-R4 amplify the FDP ionization site and 
primer F3-R5 amplify the catalytic site; the expected 
amplification bands are 1196 bp, 1750 bp, 997 bp 
and 2144 bp respectively. 
d)  Active site final lid, using F4 and R5 primers. 
This site is formed by three amino acids; Trp 271, 
Tyr 520 and Asp 524. Primer F4 sits around Trp 271 
and primer R5 sits around Asp 524. The expected 
amplification band is 1544 bp long. 
PCR conditions
PCR reactions were carried out in a total volume 
of 20 µl reaction mixture containing: 2 µl DNA 
polymerase buffer (Sib enzyme, Russia), 0.2 
mM dNTPs (Sib enzyme, Russia), 20 pmol of 
each primer, 2 units of Taq DNA polymerase (Sib 
enzyme, Russia) and 50 ng of genomic DNA. 
Thermal cycler apparatus (Techne, Model TC512, 
UK) was programmed at 94°C for 4 min, 25 cycles 
of 94°C for 40 s, 56°C for 60 s, 72°C for 2 min 
and the final extension at 72°C for 8 min. Different 
annealing temperatures were used for each pair 
of primers according to Gene Runner software 
recommendations (Table 1). PCR products were run 
on a 1% (w/v) agarose gel along with a 1kb DNA size 
marker (Cinnagen), stained by ethidium bromide 
(0.5 µg/ml) and visualized in a gel documentation 
system (UVP, USA)
Digestion of PCR products 
PCR products were digested by HindII and BglII 
enzymes. The cutting sites and the expected number 
of fragments were obtained using Gene Runner 
software. Reactions were carried out in a 20 µl 
final volume. Each reaction contained 1 µg DNA, 
2 µl of buffer (10 X), 0.2 µg BSA, 1 unit of each 
of restriction enzymes (Sibenzyme, Russia) and 
distilled sterile water. 
RESULTS
Amplification of entire am1 gene in the 10 mentioned 
Artemisia species, was the main aim of this study. 
Nevertheless, despite applying different annealing 
temperatures, extension times and PCR components 
concentrations, this amplification did not happen.
In the amplification of aspartate rich motif (DDXXD), 
all species gave a 412 bp amplification band except 
A. scoparia and A. draconculus (Fig 2a). Aspartate 
rich motif is the binding site of substrate to ADS 
enzyme (14). The expected band (1870 bp) was not 
observed in any of the species. Several unspecific 
bands were amplified in A. annua, A. austrica and A. 
chamaemelifolia (data not shown).
The F3 primer position was designed around Arg 
262 and R5 primer position around Tyr 520 and 
Asp 524 residues to find catalytic site. The expected 
amplification  band  was  observed  in  A. annua,  A. 
aucheri, A. chamaemelifolia and A. siberi (Fig. 2b). 
To investigate FDP ionization site, primers F3 and F4 
were used. Primer F3 contains the Arg 262 position 
and Primer R4 corresponds to the positions of Arg 
440 and Asp 444 on the ADS enzyme. R3 primer sits 
on a conserved sequence in terpene synthase genes 
(14). Primers F3-R4 amplified the 1750 bp fragment 
in A. annua, A. siberi, A. austrica, A. vulgaris, A. 
scoparia, A. draconculus and A. cina (Fig. 2c). F3-
R3 primers could amplify the 1196 bp fragment 
in  A. annua,  A. aucheri,  A. chamaemelifolia, A. 
vulgaris, A. siberi and A. cina (Fig. 2d). Primers F4-
R4 amplified the 997 bp fragment in A. annua, A. 
aucheri, A. chamaemelifolia, A. siberi, A. vulgaris 
and A. austrica (Fig. 2e). By using primers F4 and 
R5, the expected 1524 bp fragment was observed 
only in A. annua, A. aucheri and A. chamaemelifolia 
(Fig. 1f). To ensure that the PCR fragments 
contained the correct sequences, the products of 
F3-R4 (FDP ionization site) and F3-R5 (catalytic 
Artemisia species
primer  annua austrica aucheri scoparia chamaemelifolia vulgaris siberi cina fragrance draconculus
F1-R1 + + + - - + + + + +
F3-R3 + - + - + + + + - -
F3-R4 + + + + + + + + + +
F3-R5 + - + - + - + - - -
F4-R4 + + + - + + + - - -
F4-R5 + - + - + - - - - -
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Figure 2. PCR products obtained from the designed primers based on the am1 gene sequence with the following primer pairs: A) F1-R1 
B) F3-R5 C) F3-R4 D) F3-R3 E) F4-R4 F) F4-R5 in 10 wild artemisia species. The lanes show in order (1) 1kb DNA size marker, (2) A. 
annua, (3) A. austerica, (4) A. aucheri, (5) A. scoparia, (6) A. chamaemelifolia, (7) A. vulgaris, (8) A. siberi, (9) A. cina, (10) A. fragrance, 
(11) A. draconculus and (12) negative control.
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Figure 3. Restriction digestion of F3-R3 (A) and F3-R5 (B) amplification products. Lane (1), 1 kb DNA size marker, lanes 2-4, PCR 
products from A. annua, A. aucheri and A. chamaemelifolia, digested with BglII and lanes 5-7 PCR products from A. annua, A. aucheri 
and A. chamaemelifolia digested with HindII, respectively.
Figure 1. Primers positions in am1 gene sequence and their expected products.
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site) were amplified in A. annua, A. chammelifoli 
and A. aucheri were digested with BglII and HindII. 
The restriction fragments expected from F3-R4 
product digestion with BglII were 802, 728 and 264 
bp and the expected restriction fragments obtained 
from HindII digestion were 761, 575 and 458 bp 
long. The restriction fragments expected from F3-
R5 digestion with BglII and HindII which also 
obtained were 1151, 728, 264 bp, and 575, 480, 
327 bp long respectively. Indicating that correct 
sequences had been amplified (Figs. 3A, B). Results 
are summarized in (Table 3).
DISCUSSION
There are different medicines for treatment of 
malaria. A novel medicine on this respect is 
artemisinin, obtained from A. annua. This study was 
conducted to discover Artemisia species containing 
the  am1 gene, an important gene in artemisinin 
synthesis pathway. Since most of the studied 
species grow wildly in different areas, it was not 
possible to investigate artemisinin production in 
those species, especially at different growth stages. 
In addition, some of the species needed a stage of 
adaptation  to  the  glasshouse  or  field  conditions 
to grow. To solve each one of these problems, 
further studies were required. Therefore an initial 
study was conducted to investigate the presence of 
am1 gene. PCR was employed and primers were 
designed to amplify the entire am1 gene as well as 4 
important sequences, essential for the correct ADS 
enzyme function. Positive results were obtained 
from  several  pairs  of  primers,  amplifying  5’,  3’ 
and the middle part of the am1 gene in some of the 
Artemisia species. Nevertheless, despite applying 
a wide range of PCR conditions, the whole gene 
(4392 bp) was not amplified. However, the primers 
designed to amplify both 5’ and 3’ ends of the am1 
gene, showed positive results. This means that 
forward and reverse primers were matching the 
corresponding sequences at the two ends of the 
gene, but probably changes in some sequences in 
the gene would not allow whole gene amplification. 
This may be as a result of INDELs somewhere in 
the am1 gene sequence that prevented the whole 
gene amplification.
CONCLUSION
Result of this investigation showed that two 
Artemisia species contain the DNA sequences 
to encode the important parts of ADS enzyme 
for correct folding and function. In conclusion 
two  Artemisia species, A.  aucheri and A. 
chamaemelifolia are recommended for further 
investigation and possibly gene transfer with the 
aim of increasing artemisinin production. 
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